Literature DB >> 22377752

Smoking is not a risk factor for sporadic amyotrophic lateral sclerosis in an Australian population.

Roger Pamphlett1, Elizabeth Cochran Ward.   

Abstract

BACKGROUND: Controversy persists as to whether smoking is a risk factor for sporadic amyotrophic lateral sclerosis (SALS), the most common form of sporadic motor neuron disease (SMND). We therefore undertook a large case-control study of smoking and SALS in Australia.
METHODS: Cases and controls were recruited Australia-wide over a 10-year period. SALS and the other subgroups of SMND were categorised on the basis of neurologists' reports. Controls were partners or friends of SMND patients or community volunteers. Individuals filled in a questionnaire regarding smoking habits. A total of 809 patients with SMND (631 with SALS) and 779 controls were included in the study. SALS males and females were analysed separately.
RESULTS: No differences between SALS patients and control groups were found with regard to (1) the odds ratios of ever-smokers, ex-smokers or current smokers compared to never-smokers, (2) the means of numbers of cigarettes per day, years of smoking, pack years or age smoking began or (3) the proportions of their parents who had ever smoked. The proportion of ever-smokers and mean pack years did not differ between the clinical subgroups of SMND or between different sites of SALS onset. Partner smoking did not increase the risk of SMND.
CONCLUSION: This Australian case-control study does not support a link between cigarette smoking and any form of SMND.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22377752     DOI: 10.1159/000336013

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  8 in total

Review 1.  Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Authors:  Emanuele D'Amico; Pam Factor-Litvak; Regina M Santella; Hiroshi Mitsumoto
Journal:  Free Radic Biol Med       Date:  2013-06-21       Impact factor: 7.376

2.  Statin Medications and Amyotrophic Lateral Sclerosis Incidence and Mortality.

Authors:  Marc G Weisskopf; Joseph Levy; Aisha S Dickerson; Sabrina Paganoni; Maya Leventer-Roberts
Journal:  Am J Epidemiol       Date:  2022-06-27       Impact factor: 5.363

3.  Is the risk of motor neuron disease increased or decreased after cancer? An Australian case-control study.

Authors:  Alex Stoyanov; Roger Pamphlett
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

4.  Are people with amyotrophic lateral sclerosis (ALS) particularly nice? An international online case-control study of the Big Five personality factors.

Authors:  Jane A Parkin Kullmann; Susan Hayes; Roger Pamphlett
Journal:  Brain Behav       Date:  2018-09-21       Impact factor: 2.708

5.  Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study.

Authors:  Tommaso Filippini; Maria Fiore; Marina Tesauro; Carlotta Malagoli; Michela Consonni; Federica Violi; Elisa Arcolin; Laura Iacuzio; Gea Oliveri Conti; Antonio Cristaldi; Pietro Zuccarello; Elisabetta Zucchi; Letizia Mazzini; Fabrizio Pisano; Ileana Gagliardi; Francesco Patti; Jessica Mandrioli; Margherita Ferrante; Marco Vinceti
Journal:  Int J Environ Res Public Health       Date:  2020-01-30       Impact factor: 3.390

6.  Familial, environmental, and occupational risk factors in development of amyotrophic lateral sclerosis.

Authors:  Kamalesh Das; Chiranjib Nag; Mrinalkanti Ghosh
Journal:  N Am J Med Sci       Date:  2012-08

7.  Long-term physical activity: an exogenous risk factor for sporadic amyotrophic lateral sclerosis?

Authors:  Ceryl A Harwood; Kate Westgate; Sue Gunstone; Soren Brage; Nicholas J Wareham; Christopher J McDermott; Pamela J Shaw
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-03-21       Impact factor: 4.092

8.  Designing an Internationally Accessible Web-Based Questionnaire to Discover Risk Factors for Amyotrophic Lateral Sclerosis: A Case-Control Study.

Authors:  Jane Alana Parkin Kullmann; Susan Hayes; Min-Xia Wang; Roger Pamphlett
Journal:  JMIR Res Protoc       Date:  2015-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.